MATINAS BIOPHARMA HOLDINGS, INC. Shareholders' Equity
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Shareholders' Equity of $1.80 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.80M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.02M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $4.83M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.46M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $1.80M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.02M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $4.83M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $6.46M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $7.67M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $6.27M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $7.59M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $15.78M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $19.10M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $14.56M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $19.25M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $23.15M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $27.85M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $32.63M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $36.64M 10-K · filed 2025-04-15 | |
| 2022-09-30 | $38.62M 10-Q · filed 2023-11-08 | $38.62M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $42.85M 10-Q · filed 2023-11-08 | $42.85M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $47.68M 10-Q · filed 2023-08-09 | $47.68M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $52.49M 10-K · filed 2024-03-27 | $52.49M 10-K · filed 2022-03-08 |
| 2021-09-30 | $58.25M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $62.90M 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $66.56M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $63.73M 10-K · filed 2023-03-15 | $63.73M 10-K · filed 2021-03-29 |
| 2020-09-30 | $68.21M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $72.82M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $77.60M 10-Q · filed 2021-08-10 | |
| 2019-12-31 | $33.05M 10-K/A · filed 2022-03-11 | |
| 2019-09-30 | $37.98M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $40.42M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $43.01M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $16.14M 10-K · filed 2021-03-29 | |
| 2018-09-30 | $10.30M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $12.53M 10-Q · filed 2019-11-13 | |
| 2018-03-31 | $8.43M 10-Q · filed 2019-08-13 | |
| 2017-12-31 | $10.68M 10-K · filed 2020-03-09 | |
| 2017-09-30 | $12.78M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $15.21M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $18.86M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $7.15M 10-K · filed 2019-04-01 | $7.15M 10-K · filed 2017-03-31 |
| 2016-09-30 | $8.72M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.00M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $4.22M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $6.07M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $6.96M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $8.63M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $6.39M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $2.23M 10-K · filed 2018-03-16 | |
| 2014-09-30 | $4.75M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.46M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $8.61M 10-Q · filed 2014-06-06 | |
| 2013-12-31 | $10.47M 10-K · filed 2017-03-31 | |
| 2012-12-31 | -$116.59K 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |